Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$436,177,508
+$258,689,209 QoQ
Shares Held
3,129,637
+116.4% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9956864006912.ToString("F0")%
Shared 0.ToString("F0")%
None 0.004313599308801628.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $3,432,275,441 across 15 Drug Manufacturers - General names. GILD ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
20,422,958 | $573,476,659 | |
| 2 | MRK |
Merck & Co., Inc.
|
4,465,569 | $537,163,295 | |
| 3 | JNJ |
Johnson & Johnson
|
2,108,927 | $515,506,115 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
3,129,637 | $436,177,508 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,534,556 | $335,670,821 | |
| 6 | ABBV |
AbbVie Inc.
|
1,519,986 | $330,581,755 | |
| 7 | AMGN |
Amgen Inc
|
640,120 | $225,226,222 | |
| 8 | LLY |
ELI LILLY & Co
|
168,601 | $155,074,141 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $436,177,508 | 3,129,637 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $177,488,299 | 1,446,051 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $342,910,413 | 3,089,283 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $134,682,104 | 1,214,775 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $305,542,870 | 2,726,844 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $273,620,353 | 2,962,221 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $244,291,231 | 2,913,779 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $273,812,767 | 3,990,858 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $306,422,110 | 4,183,237 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $333,577,145 | 4,117,728 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $337,177,616 | 4,499,301 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $311,753,699 | 4,045,072 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $487,021,703 | 5,869,853 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $303,123,043 | 3,530,845 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $240,417,774 | 3,897,192 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $276,378,593 | 4,471,422 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $364,231,422 | 6,126,685 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $218,712,211 | 3,012,150 | Shares | Other | 2022-02-08 | |
| 2021-09-30 | $181,774,636 | 2,602,357 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $194,821,948 | 2,829,247 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $148,205,250 | 2,293,134 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $131,790,936 | 2,262,117 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $228,609,603 | 3,617,813 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $249,060,627 | 3,237,076 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $114,798,914 | 1,535,566 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||